Emergent role of gasotransmitters in ischemia-reperfusion injury

被引:50
作者
Moody, Bridgette F. [1 ]
Calvert, John W. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Div Cardiothorac Surg,Carlyle Fraser Heart Ctr, Atlanta, GA 30308 USA
来源
MEDICAL GAS RESEARCH | 2011年 / 1卷
基金
美国国家卫生研究院;
关键词
Nitric oxide carbon monoxide; hydrogen sulfide; cytoprotection; ischemia-reperfusion injury;
D O I
10.1186/2045-9912-1-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Nitric oxide (NO), carbon monoxide (CO) and hydrogen sulfide (H2S) are lipid-soluble, endogenously produced gaseous messenger molecules collectively known as gasotransmitters. Over the last several decades, gasotransmitters have emerged as potent cytoprotective mediators in various models of tissue and cellular injury. Specifically, when used at physiological levels, the exogenous and endogenous manipulation of these three gases has been shown to modulate ischemia/reperfusion injury by inducing a number of cytoprotective mechanisms including: induction of vasodilatation, inhibition of apoptosis, modulation of mitochondrial respiration, induction of antioxidants, and inhibition of inflammation. However, while the actions are similar, there are some differences in the mechanisms by which these gasotransmitters induce these effects and the regulatory actions of the enzyme systems can vary depending upon the gas being investigated. Furthermore, there does appear to be some crosstalk between the gases, which can provide synergistic effects and additional regulatory effects. This review article will discuss several models and mechanisms of gas-mediated cytoprotection, as well as provide a brief discussion on the complex interactions between the gasotransmitter systems.
引用
收藏
页数:9
相关论文
共 102 条
[1]   Heme oxygenase-1-derived carbon monoxide protects hearts from transplant-associated ischemia reperfusion injury [J].
Akamatsu, Y ;
Haga, M ;
Tyagi, S ;
Yamashita, K ;
Graça-Souza, AV ;
Ollinger, R ;
Czismadia, E ;
May, GA ;
Ifedigbo, E ;
Otterbein, LE ;
Bach, FH ;
Soares, MP .
FASEB JOURNAL, 2004, 18 (02) :771-+
[2]   Therapeutic applications of the gaseous mediators carbon monoxide and hydrogen sulfide [J].
Bannenberg, Gerard L. ;
Vieira, Helena L. A. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (05) :663-682
[3]   Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes [J].
Bian, JS ;
Yong, QC ;
Pan, TT ;
Feng, ZN ;
Ali, MY ;
Zhou, SF ;
Moore, PK .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (02) :670-678
[4]   Novel neural modulators [J].
Boehning, D ;
Snyder, SH .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :105-131
[6]  
Brunton TL, 1867, USE NITRITE AMYL ANG, P2
[7]   Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion [J].
Burger, Dylan ;
Xiang, Fuli ;
Hammoud, Lamis ;
Lu, Xiangru ;
Feng, Qingping .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 296 (01) :H84-H93
[8]   Erythropoietin Protects the Heart from Ventricular Arrhythmia during Ischemia and Reperfusion via Neuronal Nitric-Oxide Synthase [J].
Burger, Dylan E. ;
Xiang, Fu-Li ;
Hammoud, Lamis ;
Jones, Douglas L. ;
Feng, Qingping .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (03) :900-907
[9]   Hydrogen Sulfide Mediates Cardioprotection Through Nrf2 Signaling [J].
Calvert, John W. ;
Jha, Saurabh ;
Gundewar, Susheel ;
Elrod, John W. ;
Ramachandran, Arun ;
Pattillo, Christopher B. ;
Kevil, Christopher G. ;
Lefer, David J. .
CIRCULATION RESEARCH, 2009, 105 (04) :365-U105
[10]   Myocardial protection by nitrite [J].
Calvert, John W. ;
Lefer, David J. .
CARDIOVASCULAR RESEARCH, 2009, 83 (02) :195-203